MyFinsight
Home
Blog
About
Contact
Short-term marketable
securities
$128,846K
Cash and cash
equivalents
$34,928K
Accounts receivable
$7,809K
Prepaid expenses and
other current assets
$6,810K
Income tax receivable
$19K
Total current assets
$178,412K
Long-term marketable
securities
$63,238K
Operating lease,
right-of-use assets
$36,436K
Property and equipment,
net
$33,114K
Long-term restricted cash
$3,360K
Other long-term
assets
$144K
Total assets
$314,704K
Total liabilities and
stockholders' equity
$314,704K
Total liabilities
$198,117K
Total stockholders'
equity
$116,587K
Accumulated deficit
-$429,958K
Accumulated other
comprehensive loss
-$734K
Liability related to the
sale of future...
$97,309K
Operating lease
liabilities, net of current...
$52,777K
Total current
liabilities
$46,442K
Series 1
nonconvertible preferred stock
$1,311K
Other long-term
liabilities
$278K
Additional paid-in capital
$546,988K
Common stock 0.01 par
value per share,...
$291K
Liability related to the
sale of future...
$31,461K
Accrued expenses and
other current...
$6,859K
Accounts payable
$4,363K
Operating lease
liabilities
$3,759K
Back
Back
Balance Sheet
ENANTA PHARMACEUTICALS INC (ENTA)
ENANTA PHARMACEUTICALS INC (ENTA)
source: myfinsight.com